PPARδ comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2026-02-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Laboratory handling focuses on identity, purity, and stability. Reference standards are typically stored cold and dry, protected from light, because solutions can degrade over time. Analytical checks may use high-performance liquid chromatography with ultraviolet detection or mass spectrometry. Impurities and related substances can be separated chromatographically and compared with a known standard. Because cardarine is not an approved drug, compendial monographs are absent, and laboratories often rely on in-house methods. Reported purity varies among unregulated products and should not be assumed from a label.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid metabolism |
| Preclinical effect | Increased fatty acid oxidation | Observed in rodent studies |
| Key safety signal | Tumors in rodents after long-term exposure | Contributed to halted clinical development |
| Human trial status | No approved product; development stopped | Limited short-term metabolic data |
| Sport regulatory status | Prohibited at all times | WADA hormone and metabolic modulators class |
At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Manchester Museum organised a public discussion, "Should We Display the Dead?", which considered both Lindow Man and the Body Worlds exhibition then showing elsewhere in the city. A study by curators Jody Joy and Julia Farley examined 69 enquiries about Lindow Man received by British Museum curators between 2009 and 2018. Questions about the ethics of displaying his remains came mainly from students researching dissertations; none of the enquiries classified as coming from the general public raised that issue. Public enquiries instead tended to concern his life, death and scientific investigation. The authors distinguished these interests from the ethical questions prominent in academic and museum discussions.
The same number of families will be uprooted, business inconvenienced or lost, and farms destroyed . . .mudflats [from reservoir drawdowns] would still blight the land that now provides a classic definition of nature's beauty." He proposed legislation authorizing the Army Corps of Engineers to discover the "recreational, conservation, and preservation uses" of the river in 1972 and 1973. Then, in 1974, he introduced a House Bill that would designate the river part of the National Wild and Scenic Rivers System (NWSRS). North Carolina Senators Sam Ervin and Jesse Helms introduced a parallel bill that passed the Senate, but the House Bill stalled. It was not until 1976 that Congress would amend the Wild and Scenic Rivers Act, adding 26.5 miles of the river to the NWSRS and effectively thwarting the Blue Ridge Power Project. Also in 1974, Mizell proposed an amendment to the Legal Services Corporation Act, preventing the proposed government agency from handling desegregation suits. The amendment was included in the final version of the bill which passed. He was an opponent of desegregation busing as well, stating "Quality education...cannot be achieved while overwhelming additional expenses and administrative duties are required to implement court-ordered busing." The Watergate scandal affected Republican House members in 1974, and Mizell was upset by Democrat Stephen L. Neal, 64,634 (52.4 percent) to 59,182 (47.6 percent). Mizell had been considering running for the Senate to replace Ervin, but he opted to run for the House again, considering this a safer election bet.
However, in 2015 a study building on earlier research found that happiness has no effect on mortality. "This "basic belief that if you're happier you're going to live longer. That's just not true." Consistent results are that "apart from good health, happy people were more likely to be older, not smoke, have fewer educational qualifications, do strenuous exercise, live with a partner, do religious or group activities and sleep for eight hours a night." Happiness does however seem to have a protective impact on immunity. The tendency to experience positive emotions was associated with greater resistance to colds and flu in interventional studies irrespective of other factors such as smoking, drinking, exercise, and sleep. Positive emotional states have a favorable effect on mortality and survival in both healthy and diseased populations. Even at the same level of smoking, drinking, exercise, and sleep, happier people seem to live longer. Interventional trials conducted to establish a cause-effect relationship indicate positive emotions to be associated with greater resistance to objectively verifiable colds and flu.
Sources: en.wikipedia.org
Neo and Trinity try to jack out, but Cypher threatens to unplug them too; however, he is thwarted when Tank recovers, killing Cypher and helping Neo and Trinity jack out. Neo learns that the Agents seek to hack into Morpheus's brain in order to force him to tell them the access codes to the mainframe computer within humanity's last refuge, the city of Zion. After refusing to sacrifice Morpheus to prevent this, Neo decides to jack in and attack the building where he is being held. He and Trinity proceed to fight their way to the roof level of the building, where they are confronted by agent Jones. Neo unloads two entire magazines on Jones as he dodges each bullet effortlessly. When Jones returns fire, Neo proves capable of dodging bullets himself, fluidly moving in a way only an agent was thought to be capable of, although he is not yet as fast as them, as his leg is grazed by a bullet. Trinity then shoots Jones at point-blank range. Using an armed chopper, Neo and Trinity successfully rescue Morpheus. As Neo has just successfully rescued comrades from a building protected by heavily armed guards and agents (thought to be an unprecedented feat), Tank and Morpheus both believe that Neo is indeed the One. Neo tries to tell Morpheus what the Oracle told him, but Morpheus explains that she merely told Neo what he needed to hear; had he believed himself to be the One, he would likely not have attempted the rescue, which was a necessary step to his emergence as the One. Reaching the landline phone, Morpheus and Trinity return to the real world, but Neo is trapped by agent Smith.
=== Wound healing and fibrosis === In skin wound healing, CCN1 is highly expressed in the granulation tissue by myofibroblasts, which proliferate and rapidly synthesize ECM to maintain tissue integrity and to promote regeneration of parenchymal cells. However, excessive matrix deposition can lead to fibrosis, scarring, and loss of tissue function. In skin wounds, CCN1 accumulates in the granulation tissue as myofibroblasts proliferate, and eventually reaches a sufficiently high level to drive the myofibroblasts themselves into senescence, whereupon these cells cease to proliferate and express matrix-degrading enzymes. Thus, CCN1 limits synthesis and deposition of ECM by myofibroblasts, reducing the risk of fibrosis during wound healing. In addition to skin wound healing, CCN1 expression is elevated in remodeling cardiomyocytes after myocardial infarction, in vascular injury, and in the long bones during fracture repair. Blockade of CCN1 by antibodies inhibits bone fracture healing in mice. In the kidney, CCN1 is expressed in podocytes in normal adult and embryonic glomeruli, but expression is decreased in IgA nephropathy, diabetic nephropathy, and membranous nephropathy, particularly in diseased kidneys with severe mesangial expansion. CYR61 induction of cellular senescence in the kidney is a potential therapy to limit fibrosis.
=== Generic names === Elagolix is the generic name of the drug and its INNTooltip International Nonproprietary Name and USANTooltip United States Adopted Name. It is also known by its former developmental code names NBI-56418 and ABT-620.
=== May === 2 May – The 5% pay increase for one million NHS staff in England is signed off at a meeting between the UK government and representatives from 14 trade unions; all NHS employees but doctors and dentists are represented at the meeting. 5 May – Following her trial and conviction at Norwich Crown Court, Helen Hewlett is sentenced to seven and a half years in prison after attempting to hire a hitman to kill a colleague with whom she had a brief affair. 8 May – Data published by NHS Business Services Authority indicated the number of community pharmacies in England is at its lowest since 2015, with 1,025 pharmacies in operation, and 160 having closed in the past two years. 9 May – Several areas of England are hit by flash floods as much of the country is affected by heavy rain storms. 10 May – A major incident is declared in Somerset following heavy rain and flash flooding in southern England. The Metropolitan Police apologises for failing to disclose documents relating to the Murder of Daniel Morgan that were found in a locked cabinet at its headquarters. 12 May – David Boyd, 55, is found guilty at Newcastle Law Courts of the 1992 murder of Nikki Allan in Sunderland, Tyne and Wear. The jury of 10 women and two men spent two and a half hours of deliberating to convict Boyd of the murder. Boyd is due to be sentenced on 23 May 2023. 14 May – Chelsea defeat Manchester United 1–0 to win the 2023 Women's FA Cup final.
Sources: en.wikipedia.org
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.
Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.
Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.